Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of food on the bioavailability of labetalol.

Literature DB >> 7378263

Effect of food on the bioavailability of labetalol.

R Mäntylä, H Allonen, J Kanto, T Kleimola, R Sellman.

Abstract

Entities: Chemical

Mesh：

Substances：
Ethanolamines
Labetalol

Year: 1980 PMID： 7378263 PMCID： PMC1429980 DOI： 10.1111/j.1365-2125.1980.tb01076.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

10 in total

1. The effect of oral protein and glucose feeding of splanchnic blood flow and oxygen utilization in normal and cirrhotic subjects.

Authors: J L BRANDT; L CASTLEMAN; H D RUSKIN; J GREENWALD; J J KELLY
Journal: J Clin Invest Date: 1955-07 Impact factor: 14.808

2. Enhancement of the bioavailability of propranolol and metoprolol by food.

Authors: A Melander; K Danielson; B Scherstén; E Wåhlin
Journal: Clin Pharmacol Ther Date: 1977-07 Impact factor: 6.875

Review 3. Influence of food and diet on gastrointestinal drug absorption: a review.

Authors: P G Welling
Journal: J Pharmacokinet Biopharm Date: 1977-08

4. Altered absorption of digoxin in patients given propantheline and metoclopramide.

Authors: V Manninen; A Apajalahti; J Melin; M Karesoja
Journal: Lancet Date: 1973-02-24 Impact factor: 79.321

5. Influence of first-pass effect on availability of drugs on oral administration.

Authors: M Gibaldi; R N Boyes; S Feldman
Journal: J Pharm Sci Date: 1971-09 Impact factor: 3.534

Review 6. Influence of food on the bioavailability of drugs.

Authors: A Melander
Journal: Clin Pharmacokinet Date: 1978 Sep-Oct Impact factor: 6.447

7. The effect of crystal size, gastric content and emptying rate on the absorption of nitrofurantoin in healthy human volunteers.

Authors: P Männistö
Journal: Int J Clin Pharmacol Biopharm Date: 1978-05

8. Decreased first-pass metabolism of labetalol in chronic liver disease.

Authors: M Homeida; L Jackson; C J Roberts
Journal: Br Med J Date: 1978-10-14

9. Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism.

Authors: A J McLean; P J McNamara; P duSouich; M Gibaldi; D Lalka
Journal: Clin Pharmacol Ther Date: 1978-07 Impact factor: 6.875

10. Metabolism of labetalol by animals and man.

Authors: L E Martin; R Hopkins; R Bland
Journal: Br J Clin Pharmacol Date: 1976-08 Impact factor: 4.335

10 in total

12 in total

Review 8. Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Authors: K L Goa; P Benfield; E M Sorkin
Journal: Drugs Date: 1989-05 Impact factor: 9.546

Review 9. First-pass elimination. Basic concepts and clinical consequences.

Authors: S M Pond; T N Tozer
Journal: Clin Pharmacokinet Date: 1984 Jan-Feb Impact factor: 6.447

10. Pharmacokinetic interactions of timolol with vasodilating drugs, food and phenobarbitone in healthy human volunteers.

Authors: R Mäntylä; P Männistö; S Nykänen; A Koponen; U Lamminsivu
Journal: Eur J Clin Pharmacol Date: 1983 Impact factor: 2.953

Effect of food on the bioavailability of labetalol.

1. The effect of oral protein and glucose feeding of splanchnic blood flow and oxygen utilization in normal and cirrhotic subjects.

2. Enhancement of the bioavailability of propranolol and metoprolol by food.

Review 3. Influence of food and diet on gastrointestinal drug absorption: a review.

4. Altered absorption of digoxin in patients given propantheline and metoclopramide.

5. Influence of first-pass effect on availability of drugs on oral administration.

Review 6. Influence of food on the bioavailability of drugs.

7. The effect of crystal size, gastric content and emptying rate on the absorption of nitrofurantoin in healthy human volunteers.

8. Decreased first-pass metabolism of labetalol in chronic liver disease.

9. Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism.

10. Metabolism of labetalol by animals and man.

1. Effect of a high protein meal on the bioavailability of verapamil.

Review 2. Interactions affecting drug absorption.

3. The influence of food intake on the bioavailability of timegadine, a novel non-steroidal anti-inflammatory drug.

4. The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.

5. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog.

Review 6. Clinical pharmacokinetics of labetalol.

7. Physiological and pharmacological variability in estimated hepatic blood flow in man.

Review 8. Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Review 9. First-pass elimination. Basic concepts and clinical consequences.

10. Pharmacokinetic interactions of timolol with vasodilating drugs, food and phenobarbitone in healthy human volunteers.